Senin, 30 November 2020

Buying the Vaccine Rally Is Risky

The mainstream financial media mostly credited the Dow's first venture over 30,000 to vaccine optimism. Energy and Capital editor Luke Burgess makes the case for why that's accurate and why he believes investors shouldn't respond so bullishly to the vaccines...

Tidak ada komentar:

Posting Komentar